VAERS Explorer
Back to explore

Report #2839938

Received May 7, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
AZ
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNAUNK—IM

Symptoms (1)

Dementia Alzheimer's type

Symptom narrative

at the end had Alzheimer's; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DEMENTIA ALZHEIMER'S TYPE (at the end had Alzheimer's) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Concurrent medical conditions included Food allergy (was allergic to corn). On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced DEMENTIA ALZHEIMER'S TYPE (at the end had Alzheimer's) (seriousness criterion medically significant). At the time of the report, DEMENTIA ALZHEIMER'S TYPE (at the end had Alzheimer's) had not resolved. No concomitant medications were reported. The patient did not experience any additional symptoms or events No treatment medications were reported. Company comment: Very limited information provided in this case report precludes meaningful medical assessment. Temporal relationship was not provided, as well as the patient's age and medical history. Although there was lack of information at this point, until the date, there is no evidence to suggest that the suspect product can cause Alzheimer's disease and due to lack of biological plausibility, the causality is assessed as not related to the suspect product. The benefit-risk relationship of the product is not affected by this report. This case was linked to US-MODERNATX, INC.-MOD-2025-785740 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2025: Live follow-up received contains non-significant information and added Reference ID. On 28-Apr-2025: Live follow-up received contains non-significant information and added Reference ID. On 29-Apr-2025: Live follow-up received contains non-significant information and added Reference ID.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-785740:Master Case (Patient, Spikevax 2024-25 PFS)

Current illness

Food allergy (was allergic to corn)